 biotech monthli monitor preview
electr power util power/util monthli regulatori
off-set rocki
explor product potenti near-term
midstream oil ga midstream thought plant
andrew jeffrey oscar turner transact process
skylin champion corp hold wait cash
afford hous initi hold rohit seth
sentiment pois realiti check upgrad buy
heighten fear lithium market oversuppli weigh
alb share past mo believ investor
wrongli assum lithium commod despit high
degre technic expertis need manufactur battery-
qualiti grade electr car expect stabl low lithium
margin due favor long term contract
expect share return favor investor see evid
grow lithium capac ruinou fear
see upsid valuat ebitda upgrad
buy rais target jame sheehan
midstream oil ga tristan richardson
higher aluminum price could neg impact
compani univers ko
 william chappel jr stephani benjamin
ko acquir costa william chappel jr
electr power util
electr power util report focus regulatori
trend impact util coverag includ pend rate
case statu merger approv process new rate design
electr power util power/util macro trend
analysi key macro factor impact power/util
sector includ forward price spark spread dark spread
nation weather pattern base latest peer group
valuat decreas price target
 ali agha
midstream oil ga tristan richardson
 explor product pleas see page two
weekli sector comparison compani includ ar
wrd neal dingmann well
bcf/d m/m versu last month bcf/d trail
twelv month averag bcf/d off-shore volum
bcf/d m/m drive bcf/d m/m increas
ga product june alreadi expect see page
know growth came permian/eagl ford
bcf/d northeast bcf/d mid-con bcf/d
off-set drop rocki bcf/d well fitzpatrick
estim higher tafamidi sale rais revenue/
ep est higher tafamidi sale
popul grow compound-annual-growth-rate next yr diagnost
rate rise us prevalence/
diagnos pv/dx ttr-cm pool rise
global tafamidi sale
vs street assum use modular
us regulatori file track breakthrough therapi
design approv earli maintain hold/
ep support dcf john bori
strateg decis updat sale
estim report unchang compar
consensu report lp estim
vs prior consensu previous
note mdwd continu engag discuss multipl
least potenti strateg partner link dcf
updat progress evid medic industri
revis ekso bionic revenu estim
report medic industri prior
anticip oper loss vs prior
cash burn said still see
opportun medic rehabilit stroke spinal cord
injuri industri applic larg retain
rel valuat pt bruce nudel
 august saw increas confid
biotech sector btk nbi
outperfom growth occur primarili
small larg cap biotech name though
mid cap show moder growth august
biotech trade five-year price-to-earnings low see addit upsid
sector current favor regulatory/technolog
environ advis investor focu near-term
page
catalyst idea favor crsp
 strh biotech
momentum pipelin estimate product sale
rpt total sale rpt
rpt vs consensu rpt guidanc
lower half rang evid renew
key stock perform estimate opex prior
w/cash burn prior cash bal
end model lp unchang vs
consensu acquisit dcf base pt remain
mission health asset rais david
skylin champion corp hold wait cash
afford hous initi hold rohit seth
sentiment pois realiti check upgrad buy
heighten fear lithium market oversuppli weigh
alb share past mo believ investor
wrongli assum lithium commod despit high
degre technic expertis need manufactur battery-
qualiti grade electr car expect stabl low lithium
margin due favor long term contract
expect share return favor investor see evid
grow lithium capac ruinou fear
see upsid valuat ebitda upgrad
buy rais target jame sheehan
result wednesday septemb close call
follow day et estim price target
unchang charl bradi
report result thursday septemb
open earn call et estim price
target unchang charl bradi
preview look modest upsid consensu
estim base market share gain rpo
profession search segment due leverag intellectu
properti strong volum growth execut search
page
combin increas price uptick acknowledg
challeng comparison revenu vs
currenc translat headwind embrac
broad global organiz consult firm differenti
foundat intellectu properti tobey sommer
away posit share host investor
meet ny area cfo mark harri gain
better appreci improv consult product
annual vs year ago strategi
invest consult total revenu diversifi
compani maintain hold rate would look becom
construct share pullback tobey sommer
sale expans owl-twitt deal announc
overwatch juli lgf film slate continu
under-perform slightli indian origin seri look
track well may go wide theatr releas film
 new audio ad option test show lift advertis
kpi student plan includ free showtim tencent
neg crto exposur low-single-digit stock
page
sept pfizer inc ndr svp head ir kansa citi new
sept laboratori corpor america hold lh ndr evp/cfo vice-president ir director ir atlanta new
sept medidata solut inc mdso ndr cfo head ir denver
sept inc ndr ceo/presid vice-president financ cfo new york
sept genpact limit ndr cfo head ir mid-atlant
sept corp ndr president/ceo vice-president ir corp chicago
sept ndr svp financ ir st loui
page
sept ndr cfo ceo futur divis svp financ ir mid-atlant
sept civita solut inc civi ndr ceo chief public strategi market offic texa
sept inc ndr presid ceo cfo svp financ treasur svp ir texa
sept compani ndr chairman board/ceo senior vp/cso senior vice-president financ treasur director ir kc denver west coast new
sept defense/spac budget polici analysi dinner new york new
sept washington prime group inc ndr ceo vice-president ir corp boston
oct young gunz reit chicago
oct donaldson compani inc ndr svp cfo director ir corp kc denver new
inc ndr cfo global vice-president financ ir boston
sept self storag properti tour field lo angel
sept digit entertain market bu tour ea lgf san francisco socal
sept facil tour inc inc field socal
sept manag meeting/park tour inc field southeast
novemb lodg game leisur summit boston
page
sept estimate conf call innisfre hotel manag new
sept andrew jeffrey oscar turner transact process new york
sept ki bin michael lewi reit texa
oct ki bin michael lewi patrick schole greg miller reit mid-west
page
page
issu research report suntrust robinson humphrey inc analyst name report herebi certifi
recommend opinion express accur reflect research analyst person view
subject secur compani discuss herein part research analyst compens directli
indirectli relat specif recommend view express report
